Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2015-12-03
Summary
To find a test to elaborate a parameter for specific immunotherapy in allergic patients
Conditions
- Allergy
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Studienregister MasterAdmins · UniversitaetsSpital Zuerich
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2007-01-31
- Completion
- 2008-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen
NCT01012531 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy
NCT00470457 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study
NCT06778213 ·Status: RECRUITING ·Phase: PHASE4
-
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176 ·Status: RECRUITING
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid
NCT00540631 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
NCT00671268 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy
NCT01777438 ·Status: COMPLETED
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration
NCT00719511 ·Status: COMPLETED ·Phase: PHASE2
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis
NCT04088721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy
NCT01353079 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
NCT01393340 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis
NCT00698594 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
NCT04881461 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03655210 ·Status: COMPLETED ·Phase: PHASE3
-
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 2 Study in Adults Sensitized to Short Ragweed
NCT00670384 ·Status: WITHDRAWN ·Phase: PHASE2